These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 27210430)
1. Straightforward conversion of decoquinate into inexpensive tractable new derivatives with significant antimalarial activities. Beteck RM; Coertzen D; Smit FJ; Birkholtz LM; Haynes RK; N'Da DD Bioorg Med Chem Lett; 2016 Jul; 26(13):3006-3009. PubMed ID: 27210430 [TBL] [Abstract][Full Text] [Related]
2. Decoquinate liposomes: highly effective clearance of Plasmodium parasites causing severe malaria. Zeng S; Wang H; Tao L; Ning X; Fan Y; Zhao S; Qin L; Chen X Malar J; 2022 Jan; 21(1):24. PubMed ID: 35073922 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, antimalarial activities and cytotoxicities of amino-artemisinin-1,2-disubstituted ferrocene hybrids. de Lange C; Coertzen D; Smit FJ; Wentzel JF; Wong HN; Birkholtz LM; Haynes RK; N'Da DD Bioorg Med Chem Lett; 2018 Oct; 28(19):3161-3163. PubMed ID: 30174153 [TBL] [Abstract][Full Text] [Related]
4. Activities of 11-Azaartemisinin and N-Sulfonyl Derivatives against Asexual and Transmissible Malaria Parasites. Harmse R; Coertzen D; Wong HN; Smit FJ; van der Watt ME; Reader J; Nondaba SH; Birkholtz LM; Haynes RK; N'Da DD ChemMedChem; 2017 Dec; 12(24):2086-2093. PubMed ID: 29219249 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro antimalarial activities and cytotoxicities of amino-artemisinin-ferrocene derivatives. de Lange C; Coertzen D; Smit FJ; Wentzel JF; Wong HN; Birkholtz LM; Haynes RK; N'Da DD Bioorg Med Chem Lett; 2018 Feb; 28(3):289-292. PubMed ID: 29317166 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and activity of some quinolone derivatives against Plasmodium falciparum in vitro. Domínguez J; Basante W; Charris J; Riggione F Farmaco; 1996 Jun; 51(6):407-12. PubMed ID: 8766223 [TBL] [Abstract][Full Text] [Related]
7. The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria. Watson DJ; Laing L; Beteck RM; Gibhard L; Haynes RK; Wiesner L Front Pharmacol; 2022; 13():957690. PubMed ID: 36091789 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro. Nakornchai S; Konthiang P Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932 [TBL] [Abstract][Full Text] [Related]
9. Preliminary Evaluation of Artemisinin-Cholesterol Conjugates as Potential Drugs for the Treatment of Intractable Forms of Malaria and Tuberculosis. Morake M; Coertzen D; Ngwane A; Wentzel JF; Wong HN; Smit FJ; Birkholtz LM; Pietersen RD; Baker B; Wiid I; N'Da DD; Haynes RK ChemMedChem; 2018 Jan; 13(1):67-77. PubMed ID: 29193799 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of antimalarial 4-oxo-3-carboxyl quinolones. Zhang Y; Guiguemde WA; Sigal M; Zhu F; Connelly MC; Nwaka S; Guy RK Bioorg Med Chem; 2010 Apr; 18(7):2756-66. PubMed ID: 20206533 [TBL] [Abstract][Full Text] [Related]
11. Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers. Nilsen A; Miley GP; Forquer IP; Mather MW; Katneni K; Li Y; Pou S; Pershing AM; Stickles AM; Ryan E; Kelly JX; Doggett JS; White KL; Hinrichs DJ; Winter RW; Charman SA; Zakharov LN; Bathurst I; Burrows JN; Vaidya AB; Riscoe MK J Med Chem; 2014 May; 57(9):3818-34. PubMed ID: 24720377 [TBL] [Abstract][Full Text] [Related]
13. Role of Trifluoromethyl Substitution in Design of Antimalarial Quinolones: a Comprehensive Review. Romero AH Top Curr Chem (Cham); 2019 Mar; 377(2):9. PubMed ID: 30835005 [TBL] [Abstract][Full Text] [Related]
14. Antiplasmodial activity and cytotoxicity of 10β-aminoquinolinylethylethers of artemisinin. N'Da DD; Lombard MC; Clark JA; Connelly MC; Matheny AL; Sigal M; Guy KR Drug Res (Stuttg); 2013 Feb; 63(2):104-8. PubMed ID: 23427052 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimalarial activity of ethylene glycol oligomeric ethers of artemisinin. Steyn M; N'Da DD; Breytenbach JC; Smith PJ; Meredith S; Breytenbach WJ J Pharm Pharmacol; 2011 Feb; 63(2):278-86. PubMed ID: 21235593 [TBL] [Abstract][Full Text] [Related]
16. Bis-alkylamine quindolone derivatives as new antimalarial leads. Lavrado J; Gani K; Nobre PA; Santos SA; Figueiredo P; Lopes D; Rosário Vd; Gut J; Rosenthal PJ; Moreira R; Paulo A Bioorg Med Chem Lett; 2010 Oct; 20(19):5634-7. PubMed ID: 20801652 [TBL] [Abstract][Full Text] [Related]
17. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins. O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725 [TBL] [Abstract][Full Text] [Related]
18. Antimalarial and antiplasmodial activity of husk extract and fractions of Zea mays. Okokon JE; Antia BS; Mohanakrishnan D; Sahal D Pharm Biol; 2017 Dec; 55(1):1394-1400. PubMed ID: 28320254 [TBL] [Abstract][Full Text] [Related]
19. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis. Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499 [TBL] [Abstract][Full Text] [Related]
20. Preparation of N-sulfonyl- and N-carbonyl-11-azaartemisinins with greatly enhanced thermal stabilities: in vitro antimalarial activities. Haynes RK; Wong HN; Lee KW; Lung CM; Shek LY; Williams ID; Croft SL; Vivas L; Rattray L; Stewart L; Wong VK; Ko BC ChemMedChem; 2007 Oct; 2(10):1464-79. PubMed ID: 17768731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]